These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25626308)

  • 1. [Clinical value of 18F-FDG-PET and 11C-MET-PET in patients with plasma cell malignancy].
    Kobayashi M; Yamashita K; Takaori-Kondo A
    Nihon Rinsho; 2015 Jan; 73(1):74-9. PubMed ID: 25626308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement.
    Lapa C; Knop S; Schreder M; Rudelius M; Knott M; Jörg G; Samnick S; Herrmann K; Buck AK; Einsele H; Lückerath K
    Theranostics; 2016; 6(2):254-61. PubMed ID: 26877783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma.
    Okasaki M; Kubota K; Minamimoto R; Miyata Y; Morooka M; Ito K; Ishiwata K; Toyohara J; Inoue T; Hirai R; Hagiwara S; Miwa A
    Ann Nucl Med; 2015 Apr; 29(3):224-32. PubMed ID: 25421383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
    Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
    World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma.
    Chen M; Zhu W; Du J; Yang C; Han B; Zhou D; Huo L; Zhuang J
    Sci Rep; 2021 Nov; 11(1):22188. PubMed ID: 34773054
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lapa C; Garcia-Velloso MJ; Lückerath K; Samnick S; Schreder M; Otero PR; Schmid JS; Herrmann K; Knop S; Buck AK; Einsele H; San-Miguel J; Kortüm KM
    Theranostics; 2017; 7(11):2956-2964. PubMed ID: 28824728
    [No Abstract]   [Full Text] [Related]  

  • 9. [The value of fluorodeoxyglucose positron emission tomography in multiple myeloma].
    Adam Z; Bolcák K; Stanícek J; Pour L; Hájek R; Krejcí M; Prásek J; Neubauer J; Mareschova Y; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):207-14. PubMed ID: 16722151
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Morales-Lozano MI; Rodriguez-Otero P; Sancho L; Nuñez-Cordoba JM; Prieto E; Marcos-Jubilar M; Rosales JJ; Alfonso A; Guillen EF; San-Miguel J; Garcia-Velloso MJ
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11C-acetate PET/CT for metabolic characterization of multiple myeloma: a comparative study with 18F-FDG PET/CT.
    Ho CL; Chen S; Leung YL; Cheng T; Wong KN; Cheung SK; Liang R; Chim CS
    J Nucl Med; 2014 May; 55(5):749-52. PubMed ID: 24676754
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Hemrom A; Tupalli A; Alavi A; Kumar R
    PET Clin; 2022 Jul; 17(3):415-430. PubMed ID: 35717100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11C-Methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma.
    Lückerath K; Lapa C; Albert C; Herrmann K; Jörg G; Samnick S; Einsele H; Knop S; Buck AK
    Oncotarget; 2015 Apr; 6(10):8418-29. PubMed ID: 25762625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients].
    Solovev MV; Mendeleeva LP; Firsova MV; Aslanidi IP; Mukhortova OV; Savchenko VG
    Ter Arkh; 2019 Jul; 91(7):75-82. PubMed ID: 32598739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review.
    van Lammeren-Venema D; Regelink JC; Riphagen II; Zweegman S; Hoekstra OS; Zijlstra JM
    Cancer; 2012 Apr; 118(8):1971-81. PubMed ID: 21887677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 11C-methionine PET and 18F-fluorodeoxyglucose PET in differentiated thyroid cancer.
    Phan HT; Jager PL; Plukker JT; Wolffenbuttel BH; Dierckx RA; Links TP
    Nucl Med Commun; 2008 Aug; 29(8):711-6. PubMed ID: 18753824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic assessment of intracranial tuberculomas using 11C-methionine and 18F-FDG PET/CT.
    D'Souza MM; Sharma R; Jaimini A; Panwar P; Bansal A; Tripathi M; Varshney R; Pandey S; Mondal A
    Nucl Med Commun; 2012 Apr; 33(4):408-14. PubMed ID: 22301451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving role of FDG PET/CT in multiple myeloma imaging and management.
    Agarwal A; Chirindel A; Shah BA; Subramaniam RM
    AJR Am J Roentgenol; 2013 Apr; 200(4):884-90. PubMed ID: 23521465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
    Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
    In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.